TA-058に関する臨床的検討

柴田 弘俊; 窪田 良次; 田中 輝和; 植田 高彰; 田窪 孝行; 中村 博行; 正岡 徹

doi:10.11250/chemotherapy1953.32.Supplement2_356

CLINICAL STUDY OF TA-058

HIROTOSHI SHIBATA, RYOJI KUBOTA, TERUKAZU TANAKA, TAKAAKI UEDA, TAKAYUKI TAKUBO, HIROYUKI NAKAMURA, TORU MASAOKA

Author information

JOURNAL FREE ACCESS

1984 Volume 32 Issue Supplement2 Pages 356-358

DOI https://doi.org/10.11250/chemotherapy1953.32.Supplement2_356

Details

Abstract

TA-058, new semisynthetic penicillin, was administered to 8 severe infections cases suffering from malignant neoplasms of the hematopoietic organs.
Daily doses of TA-058 was 4 to 8 grams, and clinical efficacy was excellent in 1 case, good in 1 case, poor in 5 cases and undecided in 1 case.
No serious side effects were observed.

Corresponding author

Register with J-STAGE for free!